![Medical devices](https://www.ema.europa.eu/sites/default/files/styles/ema_carousel/public/2024-07/2024-07_Medical_devices.jpeg.webp?itok=7NYa-QOH)
Free advice and guidance available for manufacturers and notified bodies
![Woman adjusting medicine package](https://www.ema.europa.eu/sites/default/files/styles/ema_carousel/public/2024-07/2024-06_AMA-4-_WEB.png.webp?itok=79nHnQLr)
Pilot to test procedures for joint continental evaluation of medicines gets underway
![CHMP slider](https://www.ema.europa.eu/sites/default/files/styles/ema_carousel/public/2024-06/D10_WEB_CHMP%20highlights_slider%20%28NEW%29_0.png.webp?itok=GRP9Ifh2)
CHMP recommends 14 new medicines for approval in the EU
![Person tacking medicine from a shelf](https://www.ema.europa.eu/sites/default/files/styles/ema_carousel/public/2024-06/2024-06_GLP1%20recommendations-3-_WEB_homepage-banner.png.webp?itok=joNo90A0)
New recommendations to ensure these medicines reach those who need them most
![Revised transparency rules for Clinical Trials Information System (CTIS) have become applicable](https://www.ema.europa.eu/sites/default/files/styles/ema_carousel/public/2024-06/2024-06_CTIS%20transparency%20rules_WEB_homepage-banner.png.webp?itok=d_h_3vEM)
Revised transparency rules for Clinical Trials Information System (CTIS) have become applicable
![Image of annual report cover showing on laptop, leaflet, ipad, phone](https://www.ema.europa.eu/sites/default/files/styles/ema_carousel/public/2024-05/2024-05_Annual-report-2023-2-_WEB_slider.png.webp?itok=3pcvmMMB)
How we contributed to public and animal health in the European Union
Find medicine
What's new
FAQs
Latest news
The European Medicines Agency's (EMA) office is closed on Thursday 15 August 2024.
![Medical devices](https://www.ema.europa.eu/sites/default/files/styles/ema_embedded_listing/public/2024-07/2024-07_Medical_devices.jpeg.webp?itok=IgWGlk2T)
Free advice and guidance available for manufacturers and notified bodies
![Woman adjusting medicine package](https://www.ema.europa.eu/sites/default/files/styles/ema_embedded_listing/public/2024-07/2024-06_AMA-4-_WEB.png.webp?itok=wEh4tD9l)
Validating processes is an important step towards establishment of African Medicines Agency
![medicine pills and tablets](https://www.ema.europa.eu/sites/default/files/styles/ema_embedded_listing/public/2023-11/Web%20image_CHMP_standard_square.png.webp?itok=rcz6u79R)
14 new medicines recommended for approval; another 11 medicines recommended for extension of therapeutic indications
Outcomes of the Committee for Veterinary Medicinal Products (CVMP) meeting.
PRAC elects new chair
Events
EudraVigilance is the EU's system for managing and analysing information on adverse reactions to medicines which have been authorised or are being studied in clinical trials in the European Economic Area (EEA) and supports the reporting and analysis of suspected adverse reactions originating from clinical trials and the post-authorisation phase of...